HopeStage
Back to all studies
CompletedNCT05177146

Ketamine research on suicide risk in bipolarity depression

About this title

Neural Correlates of Ketamine's Anti-suicidal Effects in Bipolar Depression

Read the official source — NCT05177146
Medication studyAges 24–65Canada
The study in practice

Understand this study

Who was this study for?

Listed age limits: 24 years to 65 years.

Listed locations
TorontoSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: May 4, 2022
Recruitment status
Completed
Enrollment listed in the registry
16
Sponsor
Centre for Addiction and Mental Health
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Locations
Canada
Age range
From 24 Years to 65 Years
Official registry ID
NCT05177146
Official title
Show the full official title

Neural Correlates of Anti-suiciDal rEsponse to kEtamine in Treatment Resistant biPolar dePression (DEEPP-Study)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Intravenous Ketamine (IV).

Who was this study for?

Listed age limits: 24 years to 65 years.

Want to explore more studies?

Explore studies